AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 161 filers reported holding AKERO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,315 | -26.3% | 56,016 | -20.7% | 0.00% | -100.0% |
| Q1 2024 | $1,785 | -69.0% | 70,681 | -71.3% | 0.00% | -50.0% |
| Q4 2023 | $5,751 | -66.5% | 246,274 | -27.5% | 0.00% | -81.8% |
| Q3 2023 | $17,188 | +157.3% | 339,846 | +137.5% | 0.01% | +175.0% |
| Q2 2023 | $6,680 | +126.1% | 143,078 | +85.3% | 0.00% | +300.0% |
| Q1 2023 | $2,954 | -47.9% | 77,224 | -25.4% | 0.00% | -66.7% |
| Q4 2022 | $5,674 | -85.8% | 103,552 | +8616.5% | 0.00% | – |
| Q3 2022 | $40,000 | -64.9% | 1,188 | -90.2% | 0.00% | – |
| Q2 2022 | $114,000 | +6.5% | 12,078 | +58.7% | 0.00% | – |
| Q1 2022 | $107,000 | -92.9% | 7,610 | -89.3% | 0.00% | – |
| Q4 2021 | $1,498,000 | +375.6% | 70,860 | +403.7% | 0.00% | – |
| Q3 2021 | $315,000 | +131.6% | 14,068 | +156.9% | 0.00% | – |
| Q2 2021 | $136,000 | -63.1% | 5,476 | -57.1% | 0.00% | – |
| Q1 2021 | $369,000 | +141.2% | 12,757 | +114.8% | 0.00% | – |
| Q4 2020 | $153,000 | -39.3% | 5,938 | -27.3% | 0.00% | – |
| Q3 2020 | $252,000 | -41.9% | 8,169 | -53.0% | 0.00% | – |
| Q2 2020 | $434,000 | +635.6% | 17,399 | +525.4% | 0.00% | – |
| Q1 2020 | $59,000 | -47.3% | 2,782 | -44.6% | 0.00% | – |
| Q4 2019 | $112,000 | +83.6% | 5,018 | +88.9% | 0.00% | – |
| Q3 2019 | $61,000 | – | 2,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
| Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
| GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
| Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
| Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
| Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
| RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
| Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
| MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |